share_log

Humana (NYSE:HUM) Shares Gap Down After Analyst Downgrade

Humana (NYSE:HUM) Shares Gap Down After Analyst Downgrade

分析师降级后，Humana（纽约证券交易所代码：HUM）股价缺口下跌
Defense World ·  2023/02/03 02:31

Humana Inc. (NYSE:HUM – Get Rating) gapped down before the market opened on Thursday after TheStreet downgraded the stock from a b rating to a c+ rating. The stock had previously closed at $513.28, but opened at $499.13. Humana shares last traded at $492.19, with a volume of 245,244 shares traded.

在华尔街将Humana Inc.的股票评级从B级下调至C+级后，Humana Inc.(NYSE：HUM-GET Rating)周四开盘前股价下跌。该股此前收盘报513.28美元，开盘报499.13美元。Humana的股票最新报492.19美元，总成交量为245,244股。

A number of other equities analysts have also commented on the stock. Cowen raised their price objective on shares of Humana from $547.00 to $647.00 in a research report on Monday, November 7th. Truist Financial lifted their target price on shares of Humana from $570.00 to $650.00 in a research note on Thursday, November 3rd. Royal Bank of Canada boosted their price objective on shares of Humana from $560.00 to $637.00 and gave the company an "outperform" rating in a research report on Thursday, November 3rd. JPMorgan Chase & Co. dropped their target price on shares of Humana from $630.00 to $625.00 and set an "overweight" rating on the stock in a report on Friday, January 6th. Finally, Cowen upped their price target on shares of Humana from $547.00 to $647.00 in a research note on Monday, November 7th. Two investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Humana has an average rating of "Moderate Buy" and an average price target of $608.75.

其他一些股票分析师也对该股发表了评论。考恩在11月7日周一的一份研究报告中将Humana的股票目标价从547.00美元上调至647.00美元。Truist Financial在11月3日周四的一份研究报告中将Humana的目标股价从570.00美元上调至650.00美元。加拿大皇家银行将Humana的股价目标从560.00美元上调至637.00美元，并在11月3日周四的一份研究报告中给出了该公司“跑赢大盘”的评级。摩根大通将Humana股票的目标价从630.00美元下调至625.00美元，并在1月6日星期五的一份报告中对该股设定了“增持”评级。最后，考恩在11月7日周一的一份研究报告中将Humana的目标股价从547.00美元上调至647.00美元。两名投资分析师对该股的评级为持有，12名分析师给出了买入评级，一名分析师对该公司发出了强烈的买入评级。根据MarketBeat的数据，Humana的平均评级为“中等买入”，平均目标价为608.75美元。

Get
到达
Humana
哈门那
alerts:
警报：

Insider Buying and Selling at Humana

Humana的内幕买卖

In other Humana news, CEO Bruce D. Broussard sold 7,000 shares of the firm's stock in a transaction dated Monday, December 12th. The stock was sold at an average price of $531.92, for a total value of $3,723,440.00. Following the completion of the sale, the chief executive officer now owns 65,602 shares of the company's stock, valued at $34,895,015.84. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, insider Timothy S. Huval sold 635 shares of Humana stock in a transaction that occurred on Friday, December 16th. The stock was sold at an average price of $497.71, for a total transaction of $316,045.85. Following the completion of the transaction, the insider now directly owns 4,968 shares in the company, valued at $2,472,623.28. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Bruce D. Broussard sold 7,000 shares of the business's stock in a transaction that occurred on Monday, December 12th. The shares were sold at an average price of $531.92, for a total value of $3,723,440.00. Following the completion of the sale, the chief executive officer now owns 65,602 shares of the company's stock, valued at $34,895,015.84. The disclosure for this sale can be found here. Insiders have sold 22,635 shares of company stock worth $11,565,286 over the last quarter. Insiders own 0.39% of the company's stock.

在Humana的其他新闻中，首席执行官布鲁斯·D·布鲁萨德在12月12日星期一的交易中出售了7000股公司股票。这只股票的平均售价为531.92美元，总价值为3723,440.00美元。出售完成后，首席执行官现在拥有65,602股公司股票，价值34,895,015.84美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，该文件可通过此超链接。在相关新闻中，内部人士蒂莫西·S·休瓦尔在12月16日星期五的一笔交易中出售了635股Humana股票。该股以497.71美元的平均价格出售，总成交金额为316,045.85美元。交易完成后，这位内部人士现在直接拥有该公司4968股，价值2,472,623.28美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，该文件可以通过此超链接。此外，首席执行官布鲁斯·D·布鲁萨德在12月12日星期一的一次交易中出售了7000股该公司的股票。这些股票的平均价格为531.92美元，总价值为3,723,440.00美元。出售完成后，首席执行官现在拥有65,602股公司股票，价值34,895,015.84美元。关于这次销售的披露可以找到这里。在上个季度，内部人士已经出售了22,635股公司股票，价值11,565,286美元。内部人士持有该公司0.39%的股份。

Institutional Trading of Humana

Humana的制度性交易

Large investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in Humana by 1.3% during the third quarter. Vanguard Group Inc. now owns 11,181,313 shares of the insurance provider's stock worth $5,425,061,000 after buying an additional 147,619 shares during the last quarter. FMR LLC lifted its stake in Humana by 0.6% during the 2nd quarter. FMR LLC now owns 6,753,633 shares of the insurance provider's stock worth $3,161,173,000 after acquiring an additional 40,087 shares in the last quarter. State Street Corp increased its holdings in Humana by 1.0% during the 3rd quarter. State Street Corp now owns 5,613,554 shares of the insurance provider's stock worth $2,728,012,000 after purchasing an additional 53,899 shares during the period. Bank of New York Mellon Corp increased its holdings in Humana by 63.1% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,692,255 shares of the insurance provider's stock worth $821,065,000 after purchasing an additional 654,681 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in Humana by 0.5% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,126,002 shares of the insurance provider's stock worth $546,388,000 after purchasing an additional 5,926 shares during the period. 93.38% of the stock is currently owned by hedge funds and other institutional investors.
大型投资者最近对他们在该公司的头寸进行了调整。先锋集团第三季度增持Humana股份1.3%。先锋集团(Vanguard Group Inc.)目前持有11,181,313股这家保险公司的股票，价值5,425,061,000美元，上季度又购买了147,619股。FMR LLC在第二季度增持了Humana 0.6%的股份。FMR LLC目前拥有这家保险公司6,753,633股股票，价值3,161,173,000美元，上个季度又收购了40,087股。道富银行在第三季度增持了Humana 1.0%的股份。道富集团目前持有这家保险公司5,613,554股股票，价值2,728,012,000美元，在此期间又购买了53,899股。纽约梅隆银行(Bank Of New York Mellon Corp)第三季度增持Humana股份63.1%。纽约梅隆银行(Bank Of New York Mellon Corp)目前持有这家保险公司1,692,255股股票，价值821,065,000美元，在此期间又购买了654,681股。最后，Dimension Fund Advisors LP在第三季度增加了对Humana的持有量0.5%。Dimension Fund Advisors LP在此期间额外购买了5926股，现在拥有这家保险提供商价值546,388,000美元的股票1,126,002股。93.38%的股票目前由对冲基金和其他机构投资者持有。

Humana Trading Down 4.6 %

Humana股价下跌4.6%

The company has a market cap of $62.00 billion, a PE ratio of 22.21, a P/E/G ratio of 1.30 and a beta of 0.72. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.48. The company has a fifty day simple moving average of $511.66 and a two-hundred day simple moving average of $506.00.

该公司市值620.亿美元，市盈率22.21，市盈率1.30，贝塔系数0.72。该公司的流动比率为1.35，速动比率为1.35，债务权益比率为0.48。该公司的50日简单移动均线切入位在511.66美元，200日简单移动均线切入位在506.00美元。

Humana (NYSE:HUM – Get Rating) last announced its earnings results on Wednesday, February 1st. The insurance provider reported $1.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.46 by $0.16. The firm had revenue of $22.44 billion during the quarter, compared to analysts' expectations of $22.45 billion. Humana had a return on equity of 19.99% and a net margin of 3.07%. The business's revenue was up 6.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.24 EPS. Analysts anticipate that Humana Inc. will post 25.05 EPS for the current year.

Humana(NYSE：HUM-GET Rating)最近一次公布收益结果是在2月1日星期三。这家保险公司公布本季度每股收益(EPS)为1.62美元，高于分析师普遍预期的1.46美元和0.16美元。该公司当季营收为224.4亿美元，高于分析师预期的224.5亿美元。Humana的股本回报率为19.99%，净利润率为3.07%。该业务的收入同比增长了6.6%。去年同期，该公司每股收益为1.24美元。分析师预计Humana Inc.将公布本年度每股收益25.05美元。

Humana Company Profile

Humana公司简介

(Get Rating)

(获取评级)

Humana Inc engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Medicare, and State-based contracts.

Humana Inc.从事医疗保险服务的提供。该公司通过以下部门经营：零售、集团和专业以及医疗保健服务。零售部分包括以零售方式销售给个人的产品，包括医疗和补充计划，如联邦医疗保险，以及基于州的合同。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on Humana (HUM)
  • Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
  • Mullen Automotive Stock Gains Momentum On Positive News
  • Harley-Davidson Inc. Stock, Is It Time To Buy?
  • The Bottom Is In For Meta Platforms, Volatility Is Not Over
  • Analyzing Alaska Air's Recent Earnings
  • 免费获取StockNews.com关于Humana的研究报告(嗡嗡)
  • 凯西·伍兹的方舟创新ETF将在2023年反弹？
  • 马伦汽车公司股票因利好消息而上涨
  • 哈雷-戴维森公司的股票，是时候买入了吗？
  • Meta平台的底部已经到了，波动性还没有结束
  • 阿拉斯加航空公司近期收益分析

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

接受《Humana Daily》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Humana和相关公司的最新新闻和分析师评级的每日简要摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发